• Aucun résultat trouvé

[PDF] Top 20 Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT

Has 10000 "Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT" found on our website. Below are the top 20 most common "Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT".

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate or High-Risk Acute Myeloid Leukemia in Complete Remission: a Study From the ALWP of the EBMT

... is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...not. The documents may come ... Voir le document complet

22

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study

... Although the outcome of patients diagnosed with acute myeloid leukemia (AML) has improved, disease recur- rence remains the leading cause of treatment ... Voir le document complet

9

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

... Methods Study design and data collection This was a retrospective multicenter analysis using the dataset of the Acute Leukemia Working Party (ALWP) of ... Voir le document complet

12

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

... probability of receiving an auto- graft. Therefore, patients receiving UD-HSCT that showed significantly different characteristics compared to average autografted patients had a low ... Voir le document complet

15

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

... limitations of the currently used reduced-intensity/myeloablative conditioning (RIC/MAC) classi fication scheme we aimed to develop a tool that can capture more standardized the ... Voir le document complet

12

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...Kinetics of engraftment in patients with hematologic malignancies given ... Voir le document complet

7

Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on

Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

... Sandstedt, A., Duarte, R.F., Nagler, A. & Mohty, M. (2014) Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood ... Voir le document complet

4

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial

... 340 patients were registered in the ALL-3 study. Of the 279 patients younger than 51 years of age, 220 (79%) achieved CR after induction remission, ... Voir le document complet

9

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

... evaluated in this series: (i) non-relapse mor- tality, defined as death without previous relapse; (ii) relapse inci- dence, defined on the basis of morphological evidence of leukemia ... Voir le document complet

8

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

... NONMYELOABLATIVE OR REDUCED-INTENSITY REGIMENS Many of the reduced-intensity conditioning regimens do not meet criteria of nonmyeloablative conditioning as first proposed by ... Voir le document complet

26

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3internal tandem duplication: A position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow T

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3internal tandem duplication: A position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

... Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; 2 Department of Anatomy, Cell Biology, and Physiological ... Voir le document complet

10

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

... analyzing the impact of TMA occurrence on ...First, the incidence of TMA was lower in the non- myeloablative than in the high-dose setting in ... Voir le document complet

5

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

... intensity conditioning (RIC) regimens have al- lowed performing allogeneic hematopoietic stem cell transplantation (HSCT) in patients for whom conventional ... Voir le document complet

7

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

... to the highly aggressive nature of pPCL, our patient was frequently ...followed-up. The first signs of relapse occurred in Feb- ruary 2018; 6 months after high dose ...therapy. ... Voir le document complet

4

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

... The EBMT is a non-profit, scientific society representing more than 600 transplant centers mainly in ...Europe. The EBMT promotes all activity aiming to improve stem ... Voir le document complet

9

Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the

Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

... The introduction of the BCR-ABL–directed tyrosine kinase inhibitors (TKIs) to the front-line therapy for Ph- positive ALL has improved CR rates, the quality of responses, and ... Voir le document complet

11

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

... results in 12 patients (median age 43 years) given G-PBMC from HLA-iden- tical siblings after conditioning with cyclophosphamide (120 mg/kg) and fl udarabine (125 mg/m 2 ...consisted ... Voir le document complet

15

Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor

Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor

... L’ACSH a connu de profondes évolutions, conduisant à une augmentation continue du nombre de greffes réalisées ...des patients plus âgés ou plus fragiles ou encore le développement d’autres types de donneurs ... Voir le document complet

47

Stability of the cell dynamics in acute myeloid leukemia

Stability of the cell dynamics in acute myeloid leukemia

... of the corresponding nonlinear time-delay model, where the nonlinearities are monotone functions, we establish the global asymptotic stability under the same conditions that are ... Voir le document complet

22

Prediction of allogeneic HSCT related mortality in acute leukemia: exploring boundaries of prediction through machine learning based modeling.  A data mining study from the acute leukemia working party (ALWP) of the EBMT

Prediction of allogeneic HSCT related mortality in acute leukemia: exploring boundaries of prediction through machine learning based modeling. A data mining study from the acute leukemia working party (ALWP) of the EBMT

... Open in new tab | Download powerpoint set, number of necessary variables, and performance in specific subpopulations; Model development and analysis were performed with "WEKA" a ... Voir le document complet

3

Show all 10000 documents...